Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Navelbine in HER2-negative metastatic breast cancer
NCT03854617Phase 2Not yet recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Feb 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vinorelbine, sponsored by Chinese Academy of Medical Sciences. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
vinorelbine
Beyond the preview
Go deeper on NCT03854617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854617.